Cardiac inflammation, an intricate condition involving the inflammation of the heart tissues, emerges as a pivotal factor in various cardiovascular ailments. This inflammatory response can arise from diverse triggers, including infections, autoimmune disorders, or underlying health issues. The consequences of cardiac inflammation are profound, potentially impairing the heart's ability to pump blood efficiently. Notable manifestations such as myocarditis and pericarditis underscore the significance of timely intervention to avert the risk of heart failure. Researchers and healthcare experts are actively delving into the complex mechanisms of cardiac inflammation, aiming to develop precise interventions and preventative strategies. Comprehensive comprehension and effective management of cardiac inflammation stand as imperative measures in advancing cardiovascular health and alleviating the impact of associated diseases on individuals globally.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt